Defects in integrin complex formation promote CHKB-mediated muscular dystrophy

Area of Science:

• Biochemistry
• Cell Biology
• Molecular Biology

Background:

• Phosphatidylcholine (PC) is essential for eukaryotic cell membranes.
• Bi-allelic loss-of-function variants in CHKB cause muscular dystrophy by disrupting PC synthesis.
• The mechanism linking choline kinase deficiency to sarcolemma instability is unknown.

Purpose of the Study:

• To investigate the molecular mechanisms underlying sarcolemma integrity loss in CHKB-deficient muscular dystrophy.
• To identify specific molecular defects in affected muscles of Chkb-/- mice.
• To explore the role of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) in this process.

Main Methods:

• Analysis of Chkb-/- mouse models of muscular dystrophy.
• Assessment of sarcolemma integrity and protein localization in affected muscles.
• Cellular studies involving pharmacological inhibition of choline kinase and fluorescent PI(4,5)P2 reporters.
• Rescue experiments involving CHKB overexpression.

Main Results:

• Chkb-/- mice exhibit specific failure of the α7β1 integrin complex in affected muscles.
• Reduced sarcolemma association of PI(4,5)P2-binding proteins (vinculin, α-actinin) and decreased actin association were observed.
• Pharmacological inhibition of choline kinase caused PI(4,5)P2 reporter internalization and reduced vinculin at focal adhesions, which was rescued by CHKB re-expression.

Conclusions:

• Choline kinase deficiency disrupts sarcolemma integrity through a mechanism involving the α7β1 integrin complex and PI(4,5)P2 regulation.
• This study identifies a novel link between PC synthesis, integrin complex function, and muscle membrane stability.
• Targeting choline kinase or related pathways may offer therapeutic strategies for muscular dystrophies.